Nikki and Farhad Hafezi represented ELZA at Vision China 2026, presenting work on keratoconus epidemiology, corneal cross-linking, K-MAP and international research collaboration.
Light for Sight returned to Bukhara to complete second-eye epi-on CXL treatment for two young girls with keratoconus identified through screening in Uzbekistan
Nikki and Farhad Hafezi are representing ELZA in China this week with invited presentations on corneal cross-linking, keratoconus, refractive surgery safety, PACK-CXL, and K-MAP.
On Oʻzbekiston24, Nikki Hafezi calls for stronger local data to improve keratoconus care in Uzbekistan.
ELZA’s CEO and CMO, Nikki and Farhad Hafezi flew to Hong Kong to attend APAO 2026, including an invited symposium presentation by Prof. Farhad Hafezi on Custom CXL.
Why early keratoconus screening in children is essential for preventing vision loss and long-term disability.
ELZA joined the SCHWIND User Meeting 2025 in Bangkok to share our insights on advanced laser eye surgery.
Nikki Hafezi expands K-MAP to Andijan, Uzbekistan, expanding keratoconus screening to the Fergana Valley.
We are proud to announce that ELZA Institute’s CEO, Nikki L. Hafezi MAS IP ETHZ, will serve as Course Director for a new international program in Uzbekistan — the “Professional Development Course in Visual Sciences and Public Health”.
Nikki Hafezi, MAS IP ETHZ led the P21 program in Bukhara, combining keratoconus screening with multidisciplinary pediatric assessments for 400 children.
